Clinical Trials Browser

Completed × Fallopian Tube Neoplasms × Dasatinib × Clear all

NCT00671788 2016-04-15

A Phase II Evaluation of Dasatinib (Sprycel®, NSC #732517) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Phase 2 Completed

35 enrolled 8 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00672295 2012-12-28

PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal Cancer

Phase 1 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms